known to be involved in chromosomal deletions and transloregion, are frequently observed in T cell acute lymphoblastic cations. Interestingly clonal LOH appears to be more frequent leukemia (T-ALL). One of the most common genetic changes in T-ALL carrying TAL1 gene rearrangements.
stage of thymocyte maturation was determined using a panel of monoclonal antibodies (moAbs) including CD1, CD2, CD3, (either surface -sCD3 and cytoplasmic -cyCD3, CD3), CD5, CD7. Reactivity with moAbs was assessed by indirect Introduction immunofluorescence as previously described. 14 Patients were enrolled in 8803/33 and 9103/33 ALL proto-A variety of distinct chromosomal translocations are observed cols of the Associazione Italiana Ematologia Oncologia Pediin the malignant cells of patients with T cell acute lymphoblasatrica (AIEOP) study group, in which a Berlin-Frankfurttic leukemia (T-ALL). 1 In most of the cases different protoMunster (BFM) modified strategy was adopted. 15 oncogenes are activated as a result by juxtaposition with sequences from the T cell receptor (TCR) loci on chromosome 7 or 14. 2 The chromosomal region 1p32 is frequently involved Molecular analysis of TAL1 gene rearrangements in deletions and chromosomal translocations observed in T-ALL. 1 One of the most common genetic changes is the breakHigh molecular weight DNA was extracted according to stanage of the TAL1 gene. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] As a consequence of the translodard procedures. 16 Ten micrograms of DNA were digested cation, the TAL1 gene, originally described to be involved in with HindIII, size-fractionated on 0.7% agarose gels and transthe t(1;14)(p32;q11) translocation, is juxtaposed with ferred to nylon membranes (Gene Screen Plus; Biotechnology sequences from the TCR ␣/␦ chain locus. [3] [4] [5] [6] [7] [8] Although this System New Research Products, Boston, MA, USA) as translocation occurs in less than 3% of T-ALL patients, 8 sitedescribed. 14 TAL1 deletion was studied using a 32 P randomspecific deletions in the TAL1 gene are reported to occur in labelled SILDB probe. 13 PCR amplification of the specific 12-26% of T-ALL with apparently normal karyotype. [9] [10] [11] [12] [13] TAL1 deletion junctions was performed using 1 g of DNA, In order to investigate the presence of other subkaryotypic 12 pmol of the 5Ј SILDB primer (5Ј GGGGAGCTCGTGabnormalities involving the 1p32 chromosomal region, where GGAGAAATTAAG 3Ј) and 12 pmol of the 3Ј TAL1 db primers TAL1 gene is mapped, we evaluated losses of heterozygosity (tal 1 dbl 5Ј GCCTCGAAGGGTCCACATCTAC 3Ј; tal 1 db2 (LOH) in a series of pediatric T-ALL patients. Our findings 5Ј TTGTAAAATGGGGAGATAATGTCGAC 3Ј; tal 1 db3 5Ј -indicate that LOH at 1p32 occurs in T-ALL in the same region TGCATGCACTCTGATGAGCAGCC 3Ј; tal 1 db4 5Ј GGA-TTATAGGTGCCTGTCACCAC 3Ј; tal 1 db5 5Ј GTCCTG-CTAGCCCCATCCAGG 3Ј), 13 14 thermal cycler (Perkin Elmer Cetus) for 40 cycles using the more than 50% in the signal intensity of one allele in the leukemic DNA relative to its counterpart in constitutional DNA. following parameters: denaturation at 94°C for 5 min during the first cycle, then for 30 s, annealing at 60°C for 30 s and extension at 72°C for 30 s. After the last cycle an additional extension step of 72°C for 10 min was performed. The PCR Results products of TAL1 deletion types were fractionated by 1.6% agarose gel and visualized by UV lamp after ethidium Screening of 71 T-ALL by Southern blot analysis revealed TAL1 gene rearrangements in 16 cases (22.5%); the exact bromide staining. location of the deletions was determined by PCR amplification using SILDB and TALDB specific primers (see Materials and methods) and resulting in the identification of 13 type 1 and
Analysis of LOH at 1p32 one type 2 TAL1 deletions. 13 In one case extensive molecular analysis revealed the presence of a new coding sequence juxAnalysis of LOH at 1p32 was performed by PCR amplification of microsatellite sequences using primer pairs encompassing taposed 3Ј to the first SIL exon (R Amaru, personal communication). Eleven patients with TAL1 gene rearrangethe following loci: D1S211, D1S197, D1S200 and D1S220. 17 The microsatellite sequences were selected according to the ments and the same number without, were selected for the present study, based on the availability of frozen BM samples high degree of constitutional heterozygosity and to the location tightly linked to the TAL1 gene. The relative position during the remission phase. As previously reported in other series, 12,19 TAL1 rerrangements did not seem to confer a disfrom telomere to centromere was the following: D1S211, D1S197, TAL1, D1S200 and D1S220. The relative distance tinct clinical phenotype, with the exception for a higher white blood cell count in the cases with TAL1 gene rearranged as from D1S211 and D1S220 was calculated to be approximately 15 cm. compared with those without detectable TAL1 alterations (Table 1) . PCR amplification for microsatellite analysis was performed in a total volume of 50 l and included 100 ng DNA, 25 pmol
To determine the presence of subkaryotypic abnormalities involving the same cytogenetic region (1p32) where the TAL1 of each primer, 200 m/l of each dNTP and 0.2 U of Amplitaq DNA polymerase. The conditions used were the following: gene is mapped, polymorphic markers spanning this band were analyzed by PCR. Results obtained with samples preinitial denaturation at 95°C for 5 min was followed by 28 cycles of PCR: 1 min at 95°C (denaturation), 45 s at 55°C pared from BM at diagnosis were compared with corresponding matched samples obtained during remission. Figure 1 (annealing) and 45 s at 72°C (extension). Microsatellite analysis was performed on a 10% polyacrylamide gel followed by illustrates the results of allelic losses in representative cases. As summarized in Table 2 , analysis of LOH allowed the detecdetection by silver staining detection, as previously described.
18 LOH was assessed by densitometric laser scantion 1p changes in eight patients with at least one examined marker. LOH was more frequently observed in cases of T-ALL ning on the stained gels and was defined as a reduction of 361 lead to TSG inactivation with the most frequent being loss of the entire chromosome, deletion, mutation or disruption by translocations. According to Knudson's hypothesis, at least two 'hits' are required to inactivate a TSG. 21 One of them usually involves gross chromosomal rearrangements and leads to LOH. Although the number of patients limited any definitive conclusions on the rate of frequency of LOH in childhood T-ALL, our findings indicate that LOH occurs in a region 1p32 known to be involved in translocations and site-specific deletions. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The two most useful markers in identifying LOH have been D1S200 and D1S211 suggesting the existence of hot spot regions of deletion.
The demonstration of subkaryotypic abnormalities occurring in T-ALL is not limited to the 1p32 region. Several groups, including ours, have demonstrated that genetic deletions of different extension occur on the short arms of the 9 chromo- tive TSGs (p15 INK4B and p16 INK4A ) codifying for highly homologous small problems able to specifically inhibit two cyclin dependent serin-threonine kinases (CDK4 and CDK6).
28-30 Of Table 2 Allelic losses of markers located at chromosome 1p32 interest a new number of the p16 INK4A gene, namely p18 gene, 31 has been isolated and mapped on chromosome 1p32.
Even the p18 gene loss may occur in T-ALL, although detectable in a minor but significant percentage of cases (14%) 27 as
compared to p16 and p15 homozygous deletions. others, or alternatively multiple defects may occur almost inci-
dentally, is still unknown.
The recurrence of LOH in the T-ALL subgroup carrying the ring in adult leukemias and that it involves different chromosomes. 37 It is noteworthy that 25% of the cases displayed LOH at D1S209, which were mapped in the investigated area by carrying TAL1 rearrangements, with allelic losses detectable in six out of 11 cases with TAL1 alterations as compared with the present study. Finally, it should be considered that the region 1p32 two out of 11 cases without evidence of TAL1 gene involvement. Comparison of LOH among different patients permitted explored by the polymorphic markers used in the present study, has been indicated for the presence of TSG involved in the definition of two of the most commonly deleted regions of LOH as defined by D1S220 and D1S211.
other neoplasias. 38 The identification of the smallest deleted region and the subsequent identification of new putative genes may help to define other genetic lesions relevant for tumor transformation and progression of pediatric T-ALL. Discussion
In the present study we were able to demonstrate that LOH at the 1p32 chromosomal region is a recurring event in pediAcknowledgements atric T-ALL. LOH of a marker in tumor DNA may reflect the presence of a putative tumor suppressor gene (TSG) 
